Abstract:Background Despite great advances in the treatment of breast cancer, innovative approaches are still needed to reduce metastasis. As a minimally invasive local therapy (not standard therapy for breast cancer), microwave ablation (MWA) has been attempted to treat breast cancer, but the local effect and immune response induced by MWA have seldom been reported. Methods The clinical study was performed to determine the complete ablation rate of MWA for early-stage breast cancer. Secondary endpoints included safety and antitumor immune response. 35 subjects from this clinical study were enrolled in the current report, and the local effect was determined by pathological examinations or follow-up. To investigate MWA-induced immune response, patients treated with surgery (n=13) were enrolled as control, and blood samples were collected before and after MWA or surgery. The immune cell populations, serum cytokines, secretory immune checkpoint molecules, and T-cell receptor sequencing were analyzed. Results Of 35 enrolled patients, 32 (91.4%) showed complete ablation. Compared with surgery, MWA induced significantly increased levels of inducible co-stimulator (ICOS)+ activated CD4+ T cells and serum interferon gamma, indicating a shift in the Th1/Th2 balance toward Th1. The activated ICOS pathway was involved in the MWA-induced adaptive immune response. T-cell receptor sequencing revealed MWA of primary tumor activated T lymphocytes expansion and recognized some cancer-specific antigens. Moreover, CD4+ effector memory T-cell response was induced by MWA, and the immune response still existed after surgical resection of the ablated tumor. Conclusions MWA may not only be a promising local therapy but also a trigger of antitumor immunity for breast cancer, opening new avenues for the treatment of breast cancer. Combinatorial strategy using additional agents which boost MWA-induced immune response could be considered as potential treatment for clinical study for early breast cancer therapy.

Microwave ablation provides effective antigen for induction of anti-tumor immune response

Microwave Ablation Combined with Intra-Tumoral Inoculation of Dendritic Cells Induces Specific Immunity Against Hepatocellular Carcinoma

Microwave ablation combined with anti-PD-1 therapy enhances systemic antitumor immunity in a multitumor murine model of Hepa1-6

Microwave Ablation Combined With Attenuated Salmonella Typhimurium For Treating Hepatocellular Carcinoma In A Rat Model

Microwave Ablation in Treating Intrahepatic Recurrence of Hepatocellular Carcinoma after Liver Transplantation: an Analysis of 11 Cases

Effects of Intratumoral Injection of Immunoactivator after Microwave Ablation on Antitumor Immunity in a Mouse Model of Hepatocellular Carcinoma.

Microwave ablation and combined with adoptive immunotherapy for hepatocellular carcinoma

An empirical study of microwave ablation combined with intratumoral injection of dendritic cells in the treatment of mouse myeloma

Effect of microwave ablation of liver cancer on cellular immunity in mice

Multiple Courses of Immunotherapy with Different Immune Cell Types for Patients with Hepatocellular Carcinoma after Microwave Ablation.

Enhanced Antitumor Efficacy Through Microwave Ablation in Combination with Immune Checkpoints Blockade in Breast Cancer: A Pre-Clinical Study in a Murine Model.

Microwave ablation enhances the systemic immune response in patients with lung cancer

Distinct immunoreactions after a primary tumor microwave ablation using different heating parameters in a VX2 tumor model

Intratumoural Gm-Csf Microspheres And Ctla-4 Blockade Enhance The Antitumour Immunity Induced By Thermal Ablation In A Subcutaneous Murine Hepatoma Model

Microwave ablation induces Th1-type immune response with activation of ICOS pathway in early-stage breast cancer

Microwave Ablation is Effective Against Liver Metastases from Gastric Adenocarcinoma.

Effect of microwave ablation treatment against hepatic malignance on serum cytokine level.

Phase Ⅰ clinical study of combination therapy with microwave ablation and cellular immunotherapy in hepatocellular carcinoma.

Distinct Immunoreactions after Microwave Ablation of Primary Tumor with Different Heating Parameters in VX2 Tumor Model

Inducing the Abscopal Effect in Liver Cancer Treatment: The Impact of Microwave Ablation Power Levels and PD-1 Antibody Therapy

Thermal-responsive activation of engineered bacteria to trigger antitumor immunity post microwave ablation therapy